DANAHER CORP (DHR)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for DHR
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| DHR | Chairman of the Board | 74 | ["Co-founder of Danaher", "Former CEO of the Company from 1984 to 1990", "Strategic vision and leadership", "Understanding of shareholders' rights and interests"] | ["A", "C", "N", "Executive", "Finance", "Science & Technology", "Audit", "Compensation", "Science & Technology Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| FTV | Director | [] | [] | 2019 |
Biography sourced from the proxy statement filing.
Steven Rales is the Chairman of the Board and a co-founder of the Company who owns approximately 6% of the Company's outstanding shares, served as CEO of the Company from 1984 to 1990 and continues to serve as an executive officer of the Company. As a result of his substantial ownership stake in the Company, the Board believes that Mr. Rales is uniquely able to understand, articulate and advocate for the rights and interests of the Company's shareholders. Moreover, Mr. Rales uses his management experience with the Company and Board tenure to help ensure that the non-management directors have a keen understanding of the Company's business as well as the strategic and other risks and opportunities that the Company faces. This enables the Board to more effectively provide insight and direction to, and exercise oversight of, the Company's President and CEO and the rest of the management team responsible for the Company's day-to-day business (including with respect to risk management). Mr. Rales's strategy, leadership and executive compensation and his public company and private equity experience give him insight into technology and life science trends, acquisition strategy and financing, each of which represents an area of key strategic opportunity for the Company.